<DOC>
	<DOCNO>NCT02913495</DOCNO>
	<brief_summary>The purpose study evaluate two suggested therapy prevention recurrent preterm birth ( PTB ) woman prior spontaneous preterm birth , vaginal intramuscular progesterone determine whether vaginal progesterone superior intramuscular progesterone prevention recurrent preterm birth .</brief_summary>
	<brief_title>Vaginal Versus Intramuscular Progesterone Prevention Recurrent Preterm Birth</brief_title>
	<detailed_description>Preterm birth one leading cause neonatal morbidity mortality . One great predictor preterm birth history prior spontaneous preterm birth . Presently 17 hydroxyprogesterone caproate ( intramuscular ) FDA approve product prevention recurrent preterm birth , however recent study suggest vaginal progesterone may use purpose , may even superior . The American College Obstetrics Gynecology specify optimal route progesterone administration prevention recurrent preterm birth . It intention compare vaginal intramuscular progesterone see one superior .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Pregnant woman singleton pregnancy â‰¥18 year old Estimated gestational age less 24 0/7 week Prior spontaneous preterm birth singleton pregnancy 16 0/736 6/7 week . Patients also require provide consent , demonstrate understand purpose study , agree study protocol . History adverse reaction progesterone ; A contraindication progesterone treatment ; Placenta previa accreta ; Major fetal anomaly diagnose ultrasound know chromosomal disorder ; Multifetal gestation ; Preterm labor , premature rupture membrane , clinical chorioamnionitis , time enrollment</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Progesterone</keyword>
	<keyword>Prevention preterm birth</keyword>
</DOC>